BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8173174)

  • 21. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.
    Shen K; Yueng W; Ngan H
    Chin Med J (Engl); 1994 Sep; 107(9):648-52. PubMed ID: 7805454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidermal growth factor family in pulmonary carcinoids: immunohistochemical evidence of growth-promoting circuits.
    Battista P; Pizzicannella G; Vitullo P; Palmirotta R; Mariani-Costantini R
    Mod Pathol; 1993 Mar; 6(2):162-6. PubMed ID: 8097879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.
    Nicholson S; Sainsbury JR; Needham GK; Chambers P; Farndon JR; Harris AL
    Int J Cancer; 1988 Jul; 42(1):36-41. PubMed ID: 3391706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
    Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
    Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunohistochemical studies on epidermal growth factor receptor (EGF-R) in gynecological malignant tumor].
    Furugen Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):410-6. PubMed ID: 2066613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distribution of type IV collagen in invasive carcinoma of the uterine cervix.
    Pitt MA; Hale RJ; Buckley CH
    Histopathology; 1992 Feb; 20(2):139-43. PubMed ID: 1559668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relation between selenium and cancer of uterine cervix].
    Lou H; Wu R; Fu Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):112-4. PubMed ID: 7656799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors.
    Smith K; Fennelly JA; Neal DE; Hall RR; Harris AL
    Cancer Res; 1989 Nov; 49(21):5810-5. PubMed ID: 2790793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of epidermal growth factor receptor expression in squamous cell carcinomas of the oesophagus.
    Torzewski M; Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
    Anticancer Res; 1997; 17(5B):3915-9. PubMed ID: 9427803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptors in lung tumours.
    Berger MS; Gullick WJ; Greenfield C; Evans S; Addis BJ; Waterfield MD
    J Pathol; 1987 Aug; 152(4):297-307. PubMed ID: 3668732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cervical adenocarcinomas: diagnostic, prognostic and therapeutic aspects in a 49 case-control study].
    Martel P; Connan L; Bonnet F; Delannes M; Farnarier J; Mihura J; El Ghaoui A
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):48-54. PubMed ID: 10675833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME
    Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
    Eriksen JG; Steiniche T; Overgaard J;
    Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix].
    Yamasaki M; Maruo T; Akahori T; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):51-8. PubMed ID: 3280708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1).
    Ueda M; Ueki M; Yamada T; Okamoto Y; Maeda T; Sugimoto O; Otsuki Y
    Hum Cell; 1989 Dec; 2(4):401-10. PubMed ID: 2486664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
    Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
    Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.